BEAM-101
BTX-AUT-001
Phase 2 mab active
Quick answer
BEAM-101 for Sickle Cell Disease is a Phase 2 program (mab) at Beam Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Beam Therapeutics
- Indication
- Sickle Cell Disease
- Phase
- Phase 2
- Modality
- mab
- Status
- active